Sientra (NASDAQ:SIEN) Price Target Cut to $2.00 by Analysts at Craig Hallum
Sientra (NASDAQ:SIEN) Price Target Cut to $2.00 by Analysts at Craig Hallum
Sientra (NASDAQ:SIEN – Get Rating) had its price target trimmed by Craig Hallum to $2.00 in a research note issued to investors on Monday, Stock Target Advisor reports.
據Stock Target Advisor報道，在週一發佈給投資者的一份研究報告中，克雷格·哈勒姆將西恩特拉(納斯達克：SEN-GET評級)的目標價下調至2美元。
Other analysts have also recently issued reports about the company. Canaccord Genuity Group dropped their target price on Sientra from $8.00 to $5.00 in a report on Friday, May 13th. StockNews.com cut Sientra from a hold rating to a sell rating in a report on Tuesday, May 10th. Finally, Maxim Group reiterated a buy rating and set a $5.00 price target on shares of Sientra in a report on Friday, May 13th. One investment analyst has rated the stock with a sell rating and six have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average target price of $6.63.
其他分析師最近也發佈了有關該公司的報告。在5月13日星期五的一份報告中，Canaccel Genuity Group將Sientra的目標價從8.00美元下調至5.00美元。在5月10日週二的一份報告中，StockNews.com將Sientra的評級從持有下調至賣出。最後，Maxim Group在5月13日星期五的一份報告中重申了買入評級，併為Sientra的股票設定了5.00美元的目標價。一名投資分析師對該股的評級為賣出，六名分析師對該公司的評級為買入。根據MarketBeat.com的數據，該公司目前的普遍評級為中等買入，平均目標價為6.63美元。
Sientra Stock Up 13.0 %
西門子股價上漲13.0%
Shares of NASDAQ:SIEN opened at $1.11 on Monday. The company has a quick ratio of 0.77, a current ratio of 1.40 and a debt-to-equity ratio of 7.28. The business has a fifty day moving average of $0.95 and a two-hundred day moving average of $1.68. The stock has a market cap of $69.53 million, a P/E ratio of -1.19 and a beta of 1.95. Sientra has a 52-week low of $0.70 and a 52-week high of $6.72.
納斯達克：西安股票週一開盤報1.11美元。該公司的速動比率為0.77，流動比率為1.40，債務權益比為7.28。該業務的50日移動均線切入位在0.95美元，200日移動均線切入位在1.68美元。該股市值為6953萬美元，市盈率為-1.19，貝塔係數為1.95。Sientra的52周低點為0.70美元，52周高位為6.72美元。
Hedge Funds Weigh In On Sientra
對衝基金參與了Sientra的交易
Sientra Company Profile
Sientra公司簡介
(Get Rating)
(獲取評級)
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
Sientra，Inc.是一家醫學美學公司，在美國和國際上開發和銷售醫學美學產品。該公司提供用於隆胸和乳房再造手術的硅膠乳房植入物；乳房組織擴張器；以及Sientra圓形、Sientra TearDrop、allX2、Dermaspan、SoftSpan和BIOCORNEUM品牌的疤痕處理產品。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Sientra (SIEN)
- 3 Blowout Earnings Reports That Could Mark Turning Points
- Skyworks Solutions Is Worth A Look At These Prices
- Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
- 3 Stocks Set to Lead the Nasdaq Bull Market
- MarketBeat Podcast: ESG – Profitably Invest Your Values
- 免費獲取StockNews.com關於Sientra的研究報告(SIEN)
- 3份井噴式收益報告可能標誌着轉折點
- Skyworks Solutions值得看看這些價格
- CrowdStrike是否會延續其盈利排行榜榜首的勢頭？
- 3只股票將引領納斯達克牛市
- MarketBeat播客：ESG--有利可圖地投資你的價值
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.
接受西恩特拉日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Sientra和相關公司的最新新聞和分析師評級的每日簡明摘要。
譯文內容由第三人軟體翻譯。